NCT00318552 - Pharmacoeconomic Analysis of First Line Meropenem Versus Standard Antibiotic Treatment in Seriously Infected Secondary Nosocomial Sepsis Syndrome Patients. | Biotech Hunter

Enrollment

160

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions

Sepsis

Interventions

DRUG

Meropenem

Trial Locations (12)

Research Site, Baja

Research Site, Budapest

Research Site, Eger

Research Site, Kecskemét

Research Site, Kistarcsa

Research Site, Miskolc

Research Site, Pécs

Research Site, Siófok

Research Site, Székesfehérvár

Research Site, Szolnok

Research Site, Szombathely

Research Site, Veszprém